Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
出版年份 2017 全文链接
标题
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
作者
关键词
-
出版物
Journal of Crohns & Colitis
Volume 11, Issue 7, Pages 769-784
出版商
Oxford University Press (OUP)
发表日期
2017-01-30
DOI
10.1093/ecco-jcc/jjx009
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis
- (2016) G. D'Haens ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Predicting outcome in acute severe ulcerative colitis: comparison of the Travis and Ho scores using UK IBD audit data
- (2016) R. W. Lynch et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study
- (2016) T. Yamamoto et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study
- (2016) D. C. Baumgart et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis
- (2016) B. Ungar et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2016) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study
- (2016) Talia Zenlea et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis
- (2016) Shailja C. Shah et al. Clinical Gastroenterology and Hepatology
- Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study
- (2016) Gionata Fiorino et al. Clinical Gastroenterology and Hepatology
- Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
- (2016) Johannan F. Brandse et al. Clinical Gastroenterology and Hepatology
- 600 Multi Donor Intense Faecal Microbiota Transplantation is an Effective Treatment for Resistant Ulcerative Colitis: A Randomised Placebo-Controlled Trial
- (2016) Sudarshan Paramsothy et al. GASTROENTEROLOGY
- 767 Efficacy and Safety of Oral Tofacitinib As Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis: Results From Two Phase 3 Randomized Controlled Trials
- (2016) William Sandborn et al. GASTROENTEROLOGY
- Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis
- (2016) Franck Carbonnel et al. GASTROENTEROLOGY
- Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis
- (2016) Ho-Su Lee et al. INFLAMMATORY BOWEL DISEASES
- The Next Wave of Biological Agents for the Treatment of IBD
- (2016) Reena Khanna et al. INFLAMMATORY BOWEL DISEASES
- Preoperative Anti–tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch–anal Anastomosis
- (2016) Eran Zittan et al. INFLAMMATORY BOWEL DISEASES
- Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease
- (2016) Andrew R. Reinink et al. INFLAMMATORY BOWEL DISEASES
- Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis
- (2016) Raja Atreya et al. Journal of Crohns & Colitis
- ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update
- (2016) Silvio Danese et al. Journal of Crohns & Colitis
- Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
- (2016) Isabelle Cleynen et al. LANCET
- Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
- (2016) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis
- (2016) M. Anthony Sofia et al. Therapeutic Advances in Gastroenterology
- Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year
- (2016) Peter R Gibson et al. Clinical and Translational Gastroenterology
- Clostridium difficileInfection Worsens the Prognosis of Ulcerative Colitis
- (2016) María E Negrón et al. Canadian Journal of Gastroenterology and Hepatology
- Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed
- (2015) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies
- (2015) W. J. Sandborn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study
- (2015) Gert Van Assche et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
- (2015) Henit Yanai et al. Clinical Gastroenterology and Hepatology
- An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis
- (2015) David J. Gibson et al. Clinical Gastroenterology and Hepatology
- Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases
- (2015) Carla Felice et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Efficacy of the new infliximab biosimilar CT-P13 induction therapy in Crohn’s disease and ulcerative colitis – experiences from a single center
- (2015) Klaudia Farkas et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis
- (2015) William J. Sandborn et al. GASTROENTEROLOGY
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
- (2015) Paul Moayyedi et al. GASTROENTEROLOGY
- Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
- (2015) Noortje G. Rossen et al. GASTROENTEROLOGY
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis
- (2015) Johannan F. Brandse et al. GASTROENTEROLOGY
- Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
- (2015) Joana Torres et al. GASTROENTEROLOGY
- Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
- (2015) Brian Bressler et al. GASTROENTEROLOGY
- Anti–Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease
- (2015) Stefan D. Holubar et al. INFLAMMATORY BOWEL DISEASES
- Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal
- (2015) Estefanía Moreno-Rincón et al. INFLAMMATORY BOWEL DISEASES
- Systematic Review
- (2015) Neeraj Narula et al. INFLAMMATORY BOWEL DISEASES
- OP011. Budesonide MMX(R) 9 mg for Inducing Remission in Patients with Mild-to-Moderate Ulcerative Colitis Not Adequately Controlled with Oral 5-ASAs
- (2015) Journal of Crohns & Colitis
- Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study
- (2015) William J. Sandborn et al. Journal of Crohns & Colitis
- European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases
- (2015) Axel U Dignass et al. Journal of Crohns & Colitis
- The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
- (2015) Marcus Harbord et al. Journal of Crohns & Colitis
- Association Between the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and Outcomes in Acute Severe Ulcerative Colitis
- (2015) C. Corte et al. Journal of Crohns & Colitis
- Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort
- (2015) Krisztina B. Gecse et al. Journal of Crohns & Colitis
- Efficacy and Safety of Tacrolimus Therapy for Active Ulcerative Colitis; A Systematic Review and Meta-analysis
- (2015) Yuga Komaki et al. Journal of Crohns & Colitis
- The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial (NTR2883) and the ACCURE-UK trial: a randomised external pilot trial (ISRCTN56523019)
- (2015) Tjibbe J Gardenbroek et al. BMC Surgery
- Biosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13
- (2015) Stefan Schreiber et al. Expert Review of Gastroenterology & Hepatology
- The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13
- (2015) Walter Reinisch et al. Expert Review of Gastroenterology & Hepatology
- The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications?
- (2015) Shomron Ben-Horin et al. Expert Review of Gastroenterology & Hepatology
- Adjunct antibiotic combination therapy for steroid-refractory or -dependent ulcerative colitis: an open-label multicentre study
- (2014) K. Kato et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2 and 3
- (2014) Jean-Frederic Colombel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- First Multicenter Study of Modified Release Phosphatidylcholine “LT-02” in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses
- (2014) Max Karner et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Biological Agents for Moderately to Severely Active Ulcerative Colitis
- (2014) Silvio Danese et al. ANNALS OF INTERNAL MEDICINE
- Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease
- (2014) Henry A. Horton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fecal Calprotectin–Guided Dosing of Mesalamine in Ulcerative Colitis: Concept Proved but More Data Needed
- (2014) Niels Vande Casteele et al. Clinical Gastroenterology and Hepatology
- Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitis
- (2014) Mark Löwenberg et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology
- (2014) Geoffrey C. Nguyen et al. GASTROENTEROLOGY
- Influence of Combination Therapy with Immune Modulators on Anti-TNF Trough Levels and Antibodies in Patients with IBD
- (2014) Tamara van Schaik et al. INFLAMMATORY BOWEL DISEASES
- Long-term Combination Therapy with Infliximab Plus Azathioprine Predicts Sustained Steroid-free Clinical Benefit in Steroid-dependent Ulcerative Colitis
- (2014) Alessandro Armuzzi et al. INFLAMMATORY BOWEL DISEASES
- Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy
- (2014) K. Subramaniam et al. INTERNAL MEDICINE JOURNAL
- Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids
- (2014) Jordina Llaó et al. Journal of Crohns & Colitis
- Microbial composition analysis ofClostridium difficileinfections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations
- (2014) Chantalle Brace et al. Journal of Crohns & Colitis
- Clinical Predictors of Colectomy in Patients with Ulcerative Colitis: Systematic Review and Meta-analysis of Cohort Studies
- (2014) C. C. Dias et al. Journal of Crohns & Colitis
- Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy
- (2014) Rita Monterubbianesi et al. Journal of Crohns & Colitis
- Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2014) J.F. Rahier et al. Journal of Crohns & Colitis
- Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease
- (2014) Charlotte L. Kvasnovsky et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis
- (2013) B. Flourié et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients
- (2013) M. Sjöberg et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis
- (2013) S. Vegter et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit
- (2013) R. W. Lynch et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
- (2013) Dae Hyun Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study
- (2013) Won Park et al. ANNALS OF THE RHEUMATIC DISEASES
- Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2013) Xavier Roblin et al. Clinical Gastroenterology and Hepatology
- Prolonged preoperative hospital stay is a risk factor for complications after emergency colectomy for severe colitis
- (2013) S. A. L. Bartels et al. Colorectal Disease
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab Therapy Is Associated With Reduced Risk of Hospitalization in Patients With Ulcerative Colitis
- (2013) Brian G. Feagan et al. GASTROENTEROLOGY
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
- (2013) Simon P L Travis et al. GUT
- Infliximab in Steroid-dependent Ulcerative Colitis
- (2013) Alessandro Armuzzi et al. INFLAMMATORY BOWEL DISEASES
- 52-Week Efficacy of Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Failed Corticosteroids and/or Immunosuppressants
- (2013) Walter Reinisch et al. INFLAMMATORY BOWEL DISEASES
- Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohnʼs Disease, and Pouchitis
- (2013) Jun Shen et al. INFLAMMATORY BOWEL DISEASES
- Cost and quality-adjusted life year differences in the treatment of active ulcerative colitis using once-daily 4g or twice-daily 2g mesalazine dosing
- (2013) Mark P. Connolly et al. Journal of Crohns & Colitis
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of infliximab in acute severe ulcerative colitis: A single-centre experience
- (2013) Stephen J Halpin WORLD JOURNAL OF GASTROENTEROLOGY
- Impact ofClostridium difficilecolitis on 5-year health outcomes in patients with ulcerative colitis
- (2012) S. K. Murthy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients
- (2012) K. J. Schmidt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Once-Daily MMX® Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis
- (2012) Geert D'Haens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis
- (2012) Kavinderjit S Nanda et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis
- (2012) William J Sandborn et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy
- (2012) M. P. Powar et al. Colorectal Disease
- Probiotics in the Management of Inflammatory Bowel Disease
- (2012) Daisy Jonkers et al. DRUGS
- Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study
- (2012) William J. Sandborn et al. GASTROENTEROLOGY
- High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: Results of a meta-analysis of clinical trials
- (2012) Tessa E.H. Römkens et al. INFLAMMATORY BOWEL DISEASES
- Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: A systematic review and meta-analysis
- (2012) Brian G. Feagan et al. INFLAMMATORY BOWEL DISEASES
- Clostridium difficile Infection in the Inflammatory Bowel Disease Patient
- (2012) Adam M. Berg et al. INFLAMMATORY BOWEL DISEASES
- Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis
- (2012) Kah Hoong Chang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease
- (2011) M-H. Jen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Appendicectomy as a potential therapy for refractory ulcerative proctitis
- (2011) S. Bageacu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis
- (2011) L. Leifeld et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: defining remission in ulcerative colitis
- (2011) S. P. L. Travis et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements
- (2011) Alain Bitton et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The effect of appendectomy on the course of ulcerative colitis: a systematic review
- (2011) T. J. Gardenbroek et al. Colorectal Disease
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
- (2011) Jean Frédéric Colombel et al. GASTROENTEROLOGY
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study
- (2011) M. D. Kappelman et al. GUT
- Narcotic use for inflammatory bowel disease and risk factors during hospitalization
- (2011) Millie D. Long et al. INFLAMMATORY BOWEL DISEASES
- Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies
- (2011) Walter Reinisch et al. INFLAMMATORY BOWEL DISEASES
- Toxic megacolon
- (2011) Daniel M. Autenrieth et al. INFLAMMATORY BOWEL DISEASES
- Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis
- (2011) Haruhiko Ogata et al. INFLAMMATORY BOWEL DISEASES
- Mesalazine in left-sided ulcerative colitis: Efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing
- (2011) Bernd Bokemeyer et al. Journal of Crohns & Colitis
- Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis
- (2011) Udayakumar Navaneethan et al. Journal of Crohns & Colitis
- Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study
- (2010) A. Gustavsson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infliximab for refractory ulcerative proctitis
- (2010) G. BOUGUEN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis
- (2010) W. Kruis et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort
- (2010) N. Gies et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications
- (2010) J. Randall et al. BRITISH JOURNAL OF SURGERY
- A Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Mesalamine Suppositories 1 g at Bedtime and 500 mg Twice Daily in Patients with Active Mild-to-Moderate Ulcerative Proctitis
- (2010) Mark Lamet DIGESTIVE DISEASES AND SCIENCES
- Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
- (2010) William J. Sandborn et al. GASTROENTEROLOGY
- Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers
- (2010) S. Travis et al. GUT
- Management of acute severe ulcerative colitis
- (2010) G. Van Assche et al. GUT
- Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: A double-blind, randomized study
- (2010) Hiroaki Ito et al. INFLAMMATORY BOWEL DISEASES
- Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis
- (2010) Tilo Andus et al. INFLAMMATORY BOWEL DISEASES
- Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis
- (2010) Adam S. Cheifetz et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines
- (2010) Andrea Walch et al. Journal of Crohns & Colitis
- Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals
- (2010) Christian Mortensen et al. Journal of Crohns & Colitis
- 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial
- (2010) Volker Gross et al. Journal of Crohns & Colitis
- Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis
- (2010) Shigeki Bamba et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study
- (2010) Matthew J Grainge et al. LANCET
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis
- (2010) Li-Xuan Sang WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine
- (2009) M. WAHED et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX®with Asacol®
- (2009) C. PRANTERA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis
- (2009) Z. YANG et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Appendicectomy as a Therapy for Ulcerative Proctitis
- (2009) Terry Dorcen Bolin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal
- (2009) Andrea Cassinotti et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis
- (2009) Axel U. Dignass et al. Clinical Gastroenterology and Hepatology
- Combination Immunomodulator and Antibiotic Treatment in Patients With Inflammatory Bowel Disease and Clostridium difficile Infection
- (2009) Shomron Ben-Horin et al. Clinical Gastroenterology and Hepatology
- Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?
- (2009) Helenie Kefalakes et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis
- (2009) M. Ferrante et al. INFLAMMATORY BOWEL DISEASES
- Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis†
- (2009) Liliana Andrade Chebli et al. INFLAMMATORY BOWEL DISEASES
- European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2009) J.F. Rahier et al. Journal of Crohns & Colitis
- Mesalazine vanishing time from rectal mucosa following its topical administration
- (2009) M.T. Pimpo et al. Journal of Crohns & Colitis
- Rectal tacrolimus in the treatment of resistant ulcerative proctitis
- (2008) I. C. LAWRANCE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis
- (2008) S. YAMAMOTO et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis
- (2008) Wulfran Cacheux et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mesalamine Foam EnemaVersusMesalamine Liquid Enema in Active Left-Sided Ulcerative Colitis
- (2008) Antoine Cortot et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients
- (2008) Geoffrey C. Nguyen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial
- (2008) Gert Van Assche et al. GASTROENTEROLOGY
- Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
- (2008) W Kruis et al. GUT
- Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
- (2008) M A Kamm et al. GUT
- Clostridium difficile and inflammatory bowel disease
- (2008) Mazen Issa et al. INFLAMMATORY BOWEL DISEASES
- Cytomegalovirus infection in ulcerative colitis: A prospective, comparative study on prevalence and diagnostic strategy
- (2008) Eugeni Domènech et al. INFLAMMATORY BOWEL DISEASES
- Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis
- (2008) Michael A. Kamm et al. INFLAMMATORY BOWEL DISEASES
- Local application of tacrolimus in distal colitis: Feasible and safe
- (2008) Jolanda M. van Dieren et al. INFLAMMATORY BOWEL DISEASES
- Long-term outcome after infliximab for refractory ulcerative colitis
- (2008) Marc Ferrante et al. Journal of Crohns & Colitis
- Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications
- (2008) Hiroko Kunitake et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
- (2008) Inger Camilla Solberg et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Probiotic Escherichia coli Nissle 1917 (EcN) for Successful Remission Maintenance of Ulcerative Colitis in Children and Adolescents: an Open-Label Pilot Study
- (2008) J Henker et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started